Retrospective Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 14, 2014; 20(34): 12241-12248
Published online Sep 14, 2014. doi: 10.3748/wjg.v20.i34.12241
Figure 2
Figure 2 Kaplan-Meier survival curves of patients with colorectal cancer based on miR-193a-5p expression. A: Kaplan-Meier disease free survival curves of patients with colorectal cancer (CRC) based on miR-193a-5p expression. Patients in the low expression group had significantly lower disease free survival rates than those in the high expression group (log-rank test, P = 0.0026); B: Kaplan-Meier overall survival curves of patients with CRC based on miR-193a-5p expression. Patients in the low expression group had significantly lower overall survival rates than those in the high expression group (log-rank test, P = 0.0003); C: Kaplan-Meier disease free survival curves of patients with lymph node metastases based on miR-193a-5p expression. Patients in the low expression group had significantly lower disease free survival rates than those in high expression group (log-rank test, P = 0.0262); D: Kaplan-Meier overall survival curves of patients with lymph node metastases based on miR-193a-5p expression. Patients in the low expression group had significantly lower overall survival rates than those in high expression group (log-rank test, P = 0.0230). N: Lymph node stage; N0: Stage N0; N1: Stage N1; N2: Stage N2.